The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...

The pharmaceutical giant raised its full-year guidance after third-quarter revenue and core earnings per share topped ...

AstraZeneca Plc is increasingly looking to the United States for growth as its once fast-expanding China business faces challenges amid a probe that has battered the drug maker’s share price ...

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...

The pharmaceutical giant raised its full-year guidance after third-quarter revenue and core earnings per share topped ...